LOGICINK CORPORATION – Trademark Portfolio
Entity Type: 03
LOGICINK CORPORATION holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 5 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include LOGICINK. The owner is based in SAN FRANCISCO, CA.
953 INDIANA STREET
SAN FRANCISCO, CA 94107
Showing of trademarks Trademarks
Trademark Classifications
LOGICINK CORPORATION's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does LOGICINK CORPORATION have?
LOGICINK CORPORATION has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned.
What trademark classes does LOGICINK CORPORATION file in?
LOGICINK CORPORATION files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are LOGICINK CORPORATION's most well-known trademarks?
LOGICINK CORPORATION's registered trademark portfolio includes well-known marks such as LOGICINK. These are among 1 currently registered trademark in the portfolio.
What is LOGICINK CORPORATION's trademark registration success rate?
LOGICINK CORPORATION has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.